These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 27245829)

  • 1. Alterations in Pericyte Subpopulations Are Associated with Elevated Blood-Tumor Barrier Permeability in Experimental Brain Metastasis of Breast Cancer.
    Lyle LT; Lockman PR; Adkins CE; Mohammad AS; Sechrest E; Hua E; Palmieri D; Liewehr DJ; Steinberg SM; Kloc W; Izycka-Swieszewska E; Duchnowska R; Nayyar N; Brastianos PK; Steeg PS; Gril B
    Clin Cancer Res; 2016 Nov; 22(21):5287-5299. PubMed ID: 27245829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of passive permeability at the blood-tumor barrier in five preclinical models of brain metastases of breast cancer.
    Adkins CE; Mohammad AS; Terrell-Hall TB; Dolan EL; Shah N; Sechrest E; Griffith J; Lockman PR
    Clin Exp Metastasis; 2016 Apr; 33(4):373-83. PubMed ID: 26944053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterogeneous blood-tumor barrier permeability determines drug efficacy in experimental brain metastases of breast cancer.
    Lockman PR; Mittapalli RK; Taskar KS; Rudraraju V; Gril B; Bohn KA; Adkins CE; Roberts A; Thorsheim HR; Gaasch JA; Huang S; Palmieri D; Steeg PS; Smith QR
    Clin Cancer Res; 2010 Dec; 16(23):5664-78. PubMed ID: 20829328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HER2 antibody-drug conjugate controls growth of breast cancer brain metastases in hematogenous xenograft models, with heterogeneous blood-tumor barrier penetration unlinked to a passive marker.
    Gril B; Wei D; Zimmer AS; Robinson C; Khan I; Difilippantonio S; Overstreet MG; Steeg PS
    Neuro Oncol; 2020 Nov; 22(11):1625-1636. PubMed ID: 32386414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting Glioma Stem Cell-Derived Pericytes Disrupts the Blood-Tumor Barrier and Improves Chemotherapeutic Efficacy.
    Zhou W; Chen C; Shi Y; Wu Q; Gimple RC; Fang X; Huang Z; Zhai K; Ke SQ; Ping YF; Feng H; Rich JN; Yu JS; Bao S; Bian XW
    Cell Stem Cell; 2017 Nov; 21(5):591-603.e4. PubMed ID: 29100012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanomodulators targeting endothelial WNT and pericytes to reversibly open the blood-tumor barrier for boosted brain tumor therapy.
    Mu R; Sun H; Zeng Y; Tong Y; Tang P; Zhao M; Lv Z; Yu J; Chen Y; Lan Q; Zhen X; Han L
    J Control Release; 2024 May; 369():458-474. PubMed ID: 38575077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reactive astrocytic S1P3 signaling modulates the blood-tumor barrier in brain metastases.
    Gril B; Paranjape AN; Woditschka S; Hua E; Dolan EL; Hanson J; Wu X; Kloc W; Izycka-Swieszewska E; Duchnowska R; Pęksa R; Biernat W; Jassem J; Nayyar N; Brastianos PK; Hall OM; Peer CJ; Figg WD; Pauly GT; Robinson C; Difilippantonio S; Bialecki E; Metellus P; Schneider JP; Steeg PS
    Nat Commun; 2018 Jul; 9(1):2705. PubMed ID: 30006619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impairment of pericyte-endothelium crosstalk leads to blood-brain barrier dysfunction following traumatic brain injury.
    Bhowmick S; D'Mello V; Caruso D; Wallerstein A; Abdul-Muneer PM
    Exp Neurol; 2019 Jul; 317():260-270. PubMed ID: 30926390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Permeability changes and effect of chemotherapy in brain adjacent to tumor in an experimental model of metastatic brain tumor from breast cancer.
    Mohammad AS; Adkins CE; Shah N; Aljammal R; Griffith JIG; Tallman RM; Jarrell KL; Lockman PR
    BMC Cancer; 2018 Dec; 18(1):1225. PubMed ID: 30526520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Understanding Heterogeneity and Permeability of Brain Metastases in Murine Models of HER2-Positive Breast Cancer Through Magnetic Resonance Imaging: Implications for Detection and Therapy.
    Murrell DH; Hamilton AM; Mallett CL; van Gorkum R; Chambers AF; Foster PJ
    Transl Oncol; 2015 Jun; 8(3):176-84. PubMed ID: 26055175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pericyte-secreted IGF2 promotes breast cancer brain metastasis formation.
    Molnár K; Mészáros Á; Fazakas C; Kozma M; Győri F; Reisz Z; Tiszlavicz L; Farkas AE; Nyúl-Tóth Á; Haskó J; Krizbai IA; Wilhelm I
    Mol Oncol; 2020 Sep; 14(9):2040-2057. PubMed ID: 32534480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamic transition of the blood-brain barrier in the development of non-small cell lung cancer brain metastases.
    Uzunalli G; Dieterly AM; Kemet CM; Weng HY; Soepriatna AH; Goergen CJ; Shinde AB; Wendt MK; Lyle LT
    Oncotarget; 2019 Oct; 10(59):6334-6348. PubMed ID: 31695842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contribution of thrombin-reactive brain pericytes to blood-brain barrier dysfunction in an in vivo mouse model of obesity-associated diabetes and an in vitro rat model.
    Machida T; Takata F; Matsumoto J; Miyamura T; Hirata R; Kimura I; Kataoka Y; Dohgu S; Yamauchi A
    PLoS One; 2017; 12(5):e0177447. PubMed ID: 28489922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Region-specific permeability of the blood-brain barrier upon pericyte loss.
    Villaseñor R; Kuennecke B; Ozmen L; Ammann M; Kugler C; Grüninger F; Loetscher H; Freskgård PO; Collin L
    J Cereb Blood Flow Metab; 2017 Dec; 37(12):3683-3694. PubMed ID: 28273726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer-associated fibroblast promote transmigration through endothelial brain cells in three-dimensional in vitro models.
    Choi YP; Lee JH; Gao MQ; Kim BG; Kang S; Kim SH; Cho NH
    Int J Cancer; 2014 Nov; 135(9):2024-33. PubMed ID: 24643985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new blood-brain barrier model using primary rat brain endothelial cells, pericytes and astrocytes.
    Nakagawa S; Deli MA; Kawaguchi H; Shimizudani T; Shimono T; Kittel A; Tanaka K; Niwa M
    Neurochem Int; 2009; 54(3-4):253-63. PubMed ID: 19111869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ST6GALNAC5 Expression Decreases the Interactions between Breast Cancer Cells and the Human Blood-Brain Barrier.
    Drolez A; Vandenhaute E; Delannoy CP; Dewald JH; Gosselet F; Cecchelli R; Julien S; Dehouck MP; Delannoy P; Mysiorek C
    Int J Mol Sci; 2016 Aug; 17(8):. PubMed ID: 27529215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting glioblastoma-derived pericytes improves chemotherapeutic outcome.
    Guerra DAP; Paiva AE; Sena IFG; Azevedo PO; Silva WN; Mintz A; Birbrair A
    Angiogenesis; 2018 Nov; 21(4):667-675. PubMed ID: 29761249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of pericytic laminin in blood brain barrier integrity maintenance.
    Gautam J; Zhang X; Yao Y
    Sci Rep; 2016 Nov; 6():36450. PubMed ID: 27808256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth inhibition in a brain metastasis model by antibody delivery using focused ultrasound-mediated blood-brain barrier disruption.
    Kobus T; Zervantonakis IK; Zhang Y; McDannold NJ
    J Control Release; 2016 Sep; 238():281-288. PubMed ID: 27496633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.